Genprex, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 09/30/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | $0 | $0 | $0 | — |
| Research and development | $9.4M | $10.5M | $17.6M | $11.5M | — |
| Operating income | -$15.5M | -$21.2M | -$31.1M | -$23.8M | — |
| Income tax expense | $0 | $2,650 | $0 | $0 | — |
| Net income | -$16.2M | -$21.1M | -$30.9M | -$23.7M | — |
| Balance Sheet | |||||
| Cash and equivalents | $7.8M | $1.6M | $6.7M | $21.0M | — |
| Current assets | $8.4M | $2.1M | $7.5M | $21.5M | — |
| Total assets | $10.2M | $4.1M | $10.7M | $25.1M | $29.9M |
| Current liabilities | $2.2M | $2.5M | $3.3M | $2.8M | — |
| Total liabilities | $2.2M | $2.5M | — | — | $2.5M |
| Stockholders' equity | $8.0M | $1.6M | $7.4M | $22.3M | $27.5M |
| Cash Flow Statement | |||||
| Cash from operations | -$15.3M | -$17.9M | -$24.7M | -$17.6M | — |
| Depreciation and amortization | $0 | $6,693 | $15,004 | $25,575 | — |
| Stock-based compensation | $300,000 | $3.3M | $5.4M | $4.7M | — |
| Capital expenditure | — | — | — | $0 | — |
| Free cash flow | — | — | — | -$17.6M | — |
| Impairments | $0 | $0 | $0 | $0 | — |
Shares outstanding 10.6M · Free float 21.8%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.